Daniel M. Junius, Director at GLYCOMIMETICS INC (GLYC), bought 20,000 shares at $1.87 ($37K) on 2022-11-17, disclosed to the SEC on 2022-11-18.
Open-market purchase of $37k GLYC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| IDXX | SELL | 2023-02-17 | $2.2M | — | Filing → |
| IDXX | SELL | 2022-12-07 | $2.6M | — | Filing → |
| IDXX | SELL | 2021-08-12 | $3.3M | — | Filing → |